Expression of α(v)β3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas

Human Pathology

Volumn 28, Issue 4, 1997, Pages 443-449

  Liapis, Helen ^a,b   Adler, Lisa M ^a   Wick, Mark R ^a   Rader, Janet S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

carcinoma; human; integrins; ovary

Indexed keywords

INTEGRIN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BREAST METASTASIS; CANCER INVASION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; OVARY CARCINOMA; OVARY TUMOR; PROGNOSIS;

EID: 0031003548     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90033-2     Document Type: Article

References (23)

1. Serov SF, Scully RE, Sobin LH: Histological typing of ovarian tumours, in International Histological Classification of Tumours, no. 9, Geneva, Switzerland, World Health Organization, 1973, pp 37-38
2. Bell DA, Scully RE: Ovarian serous boderline tumors with stromal microinvasion: A report of 21 cases. HUM PATHOL 21:397-403, 1990
3. Gershenson DM, Silva EG: Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 65:578-585, 1990
4. Giancotti FG, Mainiero F: Integrin-mediated adhesion and signaling in tumorigenesis. Biochem Biophys Acta 1198:47-64, 1994
5. 3 integrins in ovarian cancer. Gynecol Oncol 58:216-225, 1995
6. 4 integrin in ovarian carcinomas. Int J Cancer 54:261-267, 1993
7. 1 fibronectin receptor suppress the transformed phenotype in CHO cells. Cell 60:849-859, 1990
8. Schreiner C, Fisher M. Hussein S, et al: Increased tumorigenicity of fibronectin deficient Chinese hamster ovary cell variants. Cancer Res 51:1738-1740, 1991
9. Yamamoto K, Murae M, Yasuda M: RGD-containing peptides inhibit experimental peritoneal seeding of human ovarian cancer cells. Acta Obstet Gynaecol Jpn 43:1687-1692, 1991
10. 3 expression by bone-residing breast cancer metastases. Diagn Mol Pathol 5:127-135, 1996
11. 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822, 1995
12. 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A 89:1557-1561, 1992
13. Zutter MM, Mazoujian G, Santoro SA: Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 137:863-870, 1990
14. Roman J, LaChance RM, Broekelmann TJ, et al: The fibronectin receptor is organized by extracellular matrix fibronectin: Implications for oncogenic transformation and for cell recognition of fibronectin matrices. J Cell Biol 108(6) 2529-2543, 1989
15. 5, and smooth muscle α-actin in heart and lung development. AmJ Respir Cell Mol Biol 6:474-480, 1992
16. Pischel KD, Hemler ME, Huang C, et al: Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol 138:226-233, 1987
17. v) in a human osteosarcoma cell line and is a substrate for protein kinase C. EMBO J 8:2955-2965, 1989
18. Shi S-R, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991
19. 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology 24:249-256, 1994
20. Shen J, Koukoulis GK, Virtanen I, et al: Immunolocalization of integrins in pleural mesotheliomas. Lab Invest 70:155A (#903), 1994
21. 1 integrin in some common epithelial tumors of the ovary and in normal equivalents. Anticancer Res 13:1-12, 1993
22. Cannistra SA, Kansas GS, Niloff J, et al: Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 53:3830-3838, 1993
23. Kirk RE: Elementary Statistics, (ed 2). Brooks/Cole Publishing Company, Montery, CA, 385-387, 1994